How big a protocol breach is "too big"? And what kind of "expectations" should a physician-scientist entertain before a clinical trial commences?
The traditional media still makes an impact in a world where most people are opportunistic (rather than directed) consumers of information.
The challenges of trying to force a neat definition into existence when the real phenomenon being defined is not neat.
How does lack of transparency -- or a gag rule -- help address a researcher's failure to disclose a conflict of interest?
- Log in to post comments